TR199701121T1 - Benazepril or combination compositions containing benazepril and valsartan. - Google Patents

Benazepril or combination compositions containing benazepril and valsartan.

Info

Publication number
TR199701121T1
TR199701121T1 TR97/01121T TR9701121T TR199701121T1 TR 199701121 T1 TR199701121 T1 TR 199701121T1 TR 97/01121 T TR97/01121 T TR 97/01121T TR 9701121 T TR9701121 T TR 9701121T TR 199701121 T1 TR199701121 T1 TR 199701121T1
Authority
TR
Turkey
Prior art keywords
benazepril
valsartan
compositions containing
combination compositions
formula
Prior art date
Application number
TR97/01121T
Other languages
Turkish (tr)
Inventor
De Gasparo Marc
Lee Webb Randy
Saul Cohen David
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TR199701121T1 publication Critical patent/TR199701121T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Yüksek tansiyon, kalpte kan basinci yetmezligi ve böbrek yetmezliginin tedavisi için eczasal kombinasyon bilesim, içerisinde (1) formülün ACE-engelleyici benazepril 'i veya formülün benazeprilat 'i veya eczacilikta kullanilan bir tuz bulunur; ve (2) formülün AT1-hasim valsartan 'i veya eczacilikta kullanilan bir tuz bulunur. Ayni zamanda yüksek tansiyon, kalpte kan basinci yetmezligi ve böbrek yetmezliginin tedavisinde kullanildigi gibi.The pharmaceutical combination composition for the treatment of high blood pressure, heart pressure and heart failure, contains (1) ACE-blocking benazepril of the formula or benazeprilate of the formula or a salt used in pharmacy; and (2) AT1-hasim valsartan of formula or a salt used in pharmacy. It is also used in the treatment of high blood pressure, heart pressure failure and kidney failure.

TR97/01121T 1995-04-07 1996-04-02 Benazepril or combination compositions containing benazepril and valsartan. TR199701121T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH101295 1995-04-07

Publications (1)

Publication Number Publication Date
TR199701121T1 true TR199701121T1 (en) 1998-03-21

Family

ID=4200393

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/01121T TR199701121T1 (en) 1995-04-07 1996-04-02 Benazepril or combination compositions containing benazepril and valsartan.

Country Status (15)

Country Link
EP (1) EP0820302A1 (en)
JP (1) JPH11503139A (en)
KR (1) KR19980703647A (en)
CN (1) CN1181019A (en)
AU (1) AU5399096A (en)
BR (1) BR9604818A (en)
CA (1) CA2214143A1 (en)
CZ (1) CZ313897A3 (en)
HU (1) HUP9801593A2 (en)
MX (1) MX9707683A (en)
NO (1) NO974400L (en)
PL (1) PL322529A1 (en)
SK (1) SK133897A3 (en)
TR (1) TR199701121T1 (en)
WO (1) WO1996031234A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11508894A (en) * 1995-06-30 1999-08-03 メルク エンド カンパニー インコーポレーテッド Method for treating renal disease using ACE inhibitor and All antagonist
CN101011390A (en) 1999-01-26 2007-08-08 诺瓦提斯公司 Use of angiotensin II receptor antagonists for treating acute myocardial infarction
RU2298418C2 (en) * 2000-04-12 2007-05-10 Новартис Аг Combination of at least two compounds chosen from groups at1-receptor antagonists or inhibitors of ace (angiotensin-converting enzyme) or inhibitors of hmg-coa-reductase (beta-hydroxy-beta-methylglutaryl-coenzyme-a-reductase)
DK1313714T3 (en) 2000-07-19 2008-12-15 Novartis Ag Valsartan salts
JP2004520268A (en) * 2000-08-22 2004-07-08 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト Pharmaceutical composition containing an angiotensin II antagonist and an angiotensin I converting enzyme inhibitor
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
WO2002049645A1 (en) * 2000-12-18 2002-06-27 Novartis Ag Therapeutic combination of amlodipine and benazepril
US6869970B2 (en) * 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN100377744C (en) * 2002-07-05 2008-04-02 安徽省生物医学研究所 Compound medicine for predicting ACEI pressure reducing medicine effect
EP1578360A4 (en) * 2002-08-28 2009-10-21 Curis Inc Conjoint administration of morphogens and ace inhibitors in treatment of chronic renal failure
EP1908469A1 (en) * 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
CN101869710A (en) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 Antihypertensive medical composite
SG176585A1 (en) 2009-05-20 2012-01-30 Boehringer Ingelheim Vetmed Pharmaceutical oral telmisartan solution
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
CN113144204A (en) * 2014-01-31 2021-07-23 詹森药业有限公司 Method for treating and preventing renal and fatty liver diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2081564C (en) * 1990-05-11 1998-02-03 Anthony Andrea Fossa Synergistic therapeutic compositions and methods
EP0629408A1 (en) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination of angiotensin converting enzyme inhibitors and AII antagonists

Also Published As

Publication number Publication date
JPH11503139A (en) 1999-03-23
SK133897A3 (en) 1998-02-04
PL322529A1 (en) 1998-02-02
EP0820302A1 (en) 1998-01-28
BR9604818A (en) 1998-06-09
CN1181019A (en) 1998-05-06
NO974400D0 (en) 1997-09-23
WO1996031234A1 (en) 1996-10-10
CZ313897A3 (en) 1998-01-14
KR19980703647A (en) 1998-12-05
NO974400L (en) 1997-09-23
AU5399096A (en) 1996-10-23
CA2214143A1 (en) 1996-10-10
MX9707683A (en) 1997-12-31
HUP9801593A2 (en) 1999-01-28

Similar Documents

Publication Publication Date Title
DE69531457D1 (en) Sulfonamide
TR199701121T1 (en) Benazepril or combination compositions containing benazepril and valsartan.
MY125150A (en) Factor vlla inhibitors
DE69326776T2 (en) USE OF N-ARYLMETHYLEN ETHYLENDIAMINTRIACETATE, N-ARYLMETHYLEN IMINODIACETAT OR N, N'-DIARYLMETHYLEN ETHYLENDIAMINDIACETAT AGAINST OXIDATIVE STRESS
SE9604786D0 (en) New compounds
UA49869C2 (en) NAPHTHYL-SUBSTITUTED BENZIMIDAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, METHOD FOR TREATMENT (VARIANTS), METHOD FOR INHIBITING HUMAN FACTOR Xa OR IIa
IL107109A0 (en) Compounds for modifying drug resistance and pharmaceutical compositions containing the same
BR9811825A (en) Use of lactobacillus to reduce the level of fibrinogen in the blood
BG103947A (en) Derivatives of 9-oxymerythromycin
YU60900A (en) Novel crystalline forms of an antiviral benzimidazole compound
FI964332A (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
MX9606503A (en) Pla2 inhibitors and their use for inhibition of intestinal cholesterol absorption.
DE69825164D1 (en) MEDICINAL PREPARATIONS CONTAINING VITAMIN D AND CALCIUM, THEIR PRODUCTION AND THERAPEUTIC USE
BR9713921A (en) Compound, pharmaceutical composition, process for logician capable of being modulated through factor xa inhibition
IL131407A0 (en) Tetrahydropyrido compounds medicaments containing the same and the use thereof
BR9913285A (en) Modulation method of memory effector t cells and compositions
TR200101163T2 (en) Bile water substituted phenyl-alkenoylguanidines, production methods, uses
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
TR199801184T2 (en) New compounds with analgesic action.
GB9505082D0 (en) Medicament
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
GB9420747D0 (en) 1,5 benzodiazepine derivatives
HUP9801894A2 (en) Use of dofetilide for the preparation of pharmaceutical compositions treating congestive heart failure
FR2754824B1 (en) NEW COMPOSITION CONTAINING CHITOSAN
IS5231A (en) Tissue factor affecting blood vessels